These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11822078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
    Galli M, Cimolin V, Valente EM, Crivellini M, Ialongo T, Albertini G.
    Disabil Rehabil; 2007 Apr 30; 29(8):659-64. PubMed ID: 17453987
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
    Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK.
    J Pediatr Orthop; 1998 Apr 30; 18(3):304-11. PubMed ID: 9600553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM, Ibrahim AI, Al-Qudah AA.
    Eura Medicophys; 2007 Sep 30; 43(3):311-8. PubMed ID: 17268388
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS, Vekris MD, Korompilias AV, Kostas JP, Ristanis SE, Soucacos PN.
    Acta Orthop Scand; 2003 Dec 30; 74(6):749-55. PubMed ID: 14763710
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA, Mooney JF, Smith BP, Walker F, Leon JM.
    J Pediatr Orthop; 2000 Dec 30; 20(1):108-15. PubMed ID: 10641699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
    Sätilä HK, Pietikäinen T, Lehtonen-Räty P, Koivikko M, Autti-Rämö I.
    Neuropediatrics; 2006 Dec 30; 37(6):344-9. PubMed ID: 17357036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N, Dursun E, Alican D.
    Int J Clin Pract; 2002 Oct 30; 56(8):564-7. PubMed ID: 12425363
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
    Massaad F, van den Hecke A, Renders A, Detrembleur C.
    Dev Med Child Neurol; 2006 Oct 30; 48(10):813-8. PubMed ID: 16978460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.